Low-cost production of a vaccine for lyme disease in maize

Ended Project Grant Awarded Last action

Award ID
R43AI152650
Recipient
Awarding agency
Obligated
$1,469,905

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $1,187,048.00 Federal
  • $282,857.00 Non-federal
Place of performance
San Luis Obispo, CA 93407, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
In keeping with the NIH's stated priority for the development of vaccines to bacterial zoonoses, our goal is to develop an effective and conveniently delivered vaccine to protect against the spirochaete, borrelia burgdorferi, the causative agent of lyme disease. The bacterium is vectored by infected ixodes species ticks between humans and mammalian reservoirs. Our chosen antigen candidate is ospa, a surface protein which presents as the spirochaete transits between the arthropod vector and the mammalian host. Vaccination with this antigen allows protective antibodies to encounter the spirochaete while still inside the tick as IT engorges with a blood meal, and has been shown to be effective as a transmission blocking vaccine. In order to develop adequate amounts of antigen for an effective and adequate immune response, we have established a proprietorial expression system using recombinant maize. An additional advantage of maize expression is that vaccine antigens can be directly administered through the oral route rather than purified for injection. In this proposal, our goal is to produce large amounts of ospa antigen candidate in maize, orally administer the antigen to mice in feed formulated from recombinant maize flour, and demonstrate that the antigen elicits a protective immune response against challenge.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $310,667 $0
Amendment $310,667 $0
Amendment $282,857 $0
Original award $282,857 $282,857

Quick answers

Who received award R43AI152650?

R43AI152650 was awarded to Applied Biotechnology Institute Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 2, 2021.

How much is award R43AI152650 worth?

$1,469,905 has been obligated on R43AI152650: $1,187,048 in federal funding and $282,857 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login